Cutaneous Graft-versus-Host-Disease;Graft-versus-Host-Disease der Haut

Hautarzt

Volumn 54, Issue 5, 2003, Pages 465-480

  Karrer, S ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Allogeneic stem cell transplantation; Bone marrow transplantation; Graft versus Host Disease; Lichenoid GvHD; Sclerodermiform GvHD

Indexed keywords

CYCLOSPORIN A;

ACUTE DISEASE; ALLOTRANSPLANTATION; CHRONIC DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; EARLY DIAGNOSIS; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; PROPHYLAXIS; PUVA; REVIEW; SKIN DISEASE; STEM CELL TRANSPLANTATION;

EID: 0037832718     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-003-0528-z     Document Type: Review

References (43)

1. Aractingi S, Chosidow O (1998) Cutaneous Graft-versus Host Disease. Arch Dermatol 34:602-612
2. Arai S, Vogelsang GB (2000) Management of graftversus-host disease. Blood Rev 14:190-204
3. Armitage JO (1994) Bone marrow transplantation. New Engl J Med 330:827-838
4. Barnes DWH, Loutit JF (1955) Spleen protection: the cellular hypothesis. In: Bacq ZM (ed) Radiobiology symposium. Butterworth, London, pp 134-135
5. Billingham RE (1966-1967) The biology of graftversus-host reactions. Harvey Lect, pp 21-78
6. Cavet J, Middleton PG, Segall M et al. (1999) Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood 94:3941-3946
7. Deeg HJ (1999) Graft-versus-host disease. In: Deeg HJ, Klingemann HG, Phillips GL, van Zant G (eds) A guide to blood and marrow transplantation, 3rd edn. Springer, Berlin Heidelberg New York Tokyo, pp 127-141
8. De Lima M, Champlin R (2001) Unrelated donor hematopoietic transplantation. Rev Clin Exp Hematol 5:100-134
9. Ferrara JL, Deeg HJ (1991) Graft-versus-host disease. N Engl J Med 324:667-674
10. Ferrara JL, Deeg HJ, Burakoff SJ (1997) Graft-vs-host disease, 2nd edn. Marcel Dekker Inc., New York
11. Gilliam AG, Murphy GF (1997) Cellular pathology of cutaneous graft-versus-host disease. In: Ferrara JLM, Deeg HJ, Burakoff SJ, (eds) Graft-vs.-host disease, 2nd edn. Marcel Dekker Inc., New York, pp 291-313
12. Glucksberg H, Storb R, Ferer A et al. (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 18:295-304
13. Goulmy E, Schipper R, Pool J et al. (1996) Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 334:281-285
14. Grimm J, Zeller W, Zander AR (1998) Soluble interleukin-2 receptor serum levels after allogeneic bone marrow transplantations as a marker for GvHD. Bone Marrow Transplant 21:29-32
15. Heymer B (2002) Clinical and diagnostic pathology of graft-versus-host disease. Springer, Berlin Heidelberg New York Tokyo
16. Holler E, Kolb HJ, Hintermeier-Knabe R et al. (1993) Role of tumor necrosis factor alpha in acute graft-versus disease and complications following allogeneic bone marrow transplantation. Transplant Proc 25:1234-1236
17. Holler E, Ertl B, Hintermeier-Knabe R et al. (1997) Inflammatory reactions induced by pretransplant conditioning - an alternative target for modulation of acute GvHD and complications following allogeneic bone marrow transplantation? Leuk Lymphoma 25:217-224
18. Holler E, Kolb HJ, Eissner G, Wilmanns W (1998) Cytokines in GvH and GvL. Bone Marrow Transplant [Suppl 4] 22:53-6
19. Horn TD, Zahurak ML, Atkins D et al. (1997) Lichen planus-like histopathologic characteristics in the cutaneous graft-versus-host reaction. Arch Dermatol 133:961-965
20. Jacobsohn DA, Vogelsang GB (2002) Novel pharmacotherapeutic approaches to prevention and treatment of GVHD. Drugs 62:879-889
21. Janin-Mercier A, Socie G, Devergie A et al. (1994) Fasciitis in chronic graft-versus-host disease. Ann Intern Med 120:993-998
22. Johnson CMJ, Farmer ER (1998) Graft-versus-host reactions in dermatology. J Am Acad Dermatol 38:369-392
23. Karrer S, Holler E, Szeimies RM (2001) Kutane Manifestationen der Graft-versus-Host-Reaktion. Med Klin 96:457-466
24. Klingebiel T, Schlegel PG (1998) GVHD: overview on pathophysiology, incidence, clinical and biological features. Bone Marrow Transplant [Suppl 2] 21:S45-S49
25. Lerner KG, Kao GF, Storb R et al.(1974) Histopathology of graft-versus-host reaction (GvHR) in human recipients of marrow from HLA-matched sibling donors. Transplant Proc 6:367-371
26. Link H, Kolb HJ, Ebell W et al. (1997) Die Transplantation hämatopoetischer Stammzellen. Teil I: Definitionen, prinzipielle Anwendungsmöglichkeiten, Komplikationen. Med Klin 92:480-491
27. Link H, Kolb HJ, Ebell W et al. (1997) Die Transplantation hämatopoetischer Stammzellen. Teil II: Indikationen zur Transplantation von hämatopoetischen Stammzellen nach myeloablativer Therapie. Med Klin 92:534-545
28. Lycka BAS, Kaye VN (1988) Acute follicular graft-versushost disease. Arch Dermatol 124:1442-1424
29. Nestel FP, Price KS, Seemayer TA, Lapp WS (1992) Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graftversus-host disease. J Exp Med 175:405-413
30. Ochs LA, Blazar BR, Roy Jet al. (1996) Cytokine expression in human chronic graft-versus-host disease. Bone Marrow Transplant 17:1085-1092
31. Przepiorka D, Weisdorf D, Martin P et al. (1995) 1994 Consensus conference on acute GvHD grading. Bone Marrow Transplant 15:825-828
32. Przepiorka D, Anderlini P, Saliba R et al. (2001) Chronic graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 98:1695-1700
33. Rowlings PA, Przepiorka D, Klein JP et al. (1997) IBMTR Severity Index for grading acute graft-versus-host disease; retrospective comparison with Glucksberg grade. Br J Haematol 97:855-864
34. Sale G, Beauchamp M (1993) The parafollicular hair bulge in human GvHD: a stem cell rich primary target. Bone Marrow Transplant 11:223-225
35. Sullivan KM, Deeg HJ, Sanders J, et al. (1986) Hyperacute graft-versus-host disease in patients not given immunosuppression after allogeneic bone marrow transplantation. Blood 67:1172-1175
36. Sullivan KM (1999) Graft-versus-host disease. In: Thomas ED, Blume KG, Jorman SJ (eds) Hematopoietic cell transplantation, 2nd edn. Blackwell Science Inc, Malden, pp 515-536
37. Tabbara IA, Zimmerman K, Morgan C, Nahleh Z (2002) Allogeneic hematopoietic stem cell transplantation. Complications and results. Arch Intern Med 162:1558-1566
38. Takeda H, Mitsuhashi Y, Kondo S et al. (1997) Toxic epidermal necrolysis possibly linked to hyperacute graftversus-host disease. J Dermatol 24:635-641
39. Thomas ED, Storb R, Clift RA et al. (1975) Bone-marrow transplantation. N Engl J Med 292:895-902
40. Tsoi M, Storb R, Jones E et al. (1978) Deposition of IgM and complement at the dermoepidermal junction in acute and chronic cutaneous graft-versus-host disease in man. J Immnol 120:1485-1492
41. Valks R, Fernandez-Herrera J, Bartolome B et al. (2001) Late appearance of acute graft-vs-host disease after suspending or tapering immunosuppressive drugs. Arch Dermatol 137:61-65
42. Vogelsang GB (2001) How I treat chronic graft-versushost disease. Blood 97:1196-1201
43. Volc-Platzer B (1992) Graft-versus-host disease. Hautarzt 43:669-677